The goal of this research is to test the following hypothesis: adducin plays a critical role in the assembly, stability, and function of the membrane skeleton in red blood cells (RBCs), platelets and the kidney. Genetic defects in adducin result in anemia, platelet dysfunction, and aberrant control of systemic blood pressure. The membrane skeleton is a critical component of most vertebrate cells. In vitro studies in mammalian cells and studies in other organisms such as D. melanogaster suggest that adducin plays a critical role in the developmental assembly of the membrane skeleton in the red blood cell (RBC), while data have also emerged showing that adducin is a component of the platelet membrane skeleton and is important in platelet function (e. g., aggregation, formation of filopodia and lamellipodia). Moreover, adducin polymorphisms have been associated with altered RBC and kidney cation transport activity and a hypertensive phenotype in the Milan hypertensive (MHS) rat strain. Notably, the cation transport differences between MHS and normotensive (MNS) control rats are abolished upon removal of the membrane skeleton. In humans, adducin polymorphisms have been associated with hypertension in some but not all populations. Here, we will determine the role of adducin in RBC membrane skeleton assembly and stabilization of the lipid bilayer, platelet function, and RBC cation transport activity and the regulation of systemic blood pressure in vivo using genetically defined mice.
The specific aims are to: (1) Determine the role of adducin in RBC membrane skeleton assembly and stabilization. We will generate conditional knockouts of the adducin genes in mice using the loxP system and an interferon-inducible Cre-expressing promoter strain (Mxl-Cre) and perform a complete analysis of the RBC phenotype of each mutant strain (singly and in combination). (2) Determine the role of adducin in platelet physiology and pathophysiology. We will perform a complete battery of platelet function tests in adducin null strains to assess shape change, adhesion and spreading, clot retraction, secretion, aggregation, phosphatidylserine exposure and the incidence of thrombi and infarcts. (3) Determine the role of adducin in RBC cation transport and systemic blood pressure regulation. We will determine RBC cation transporter rates (which mirror transport activities in the kidney), systolic blood pressure and heart rates in adducin null strains. Follow up studies will include electrocardiology and echocardiology.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL075714-01
Application #
6702759
Study Section
Hemostasis and Thrombosis Study Section (HT)
Program Officer
Qasba, Pankaj
Project Start
2003-12-01
Project End
2007-11-30
Budget Start
2003-12-01
Budget End
2004-11-30
Support Year
1
Fiscal Year
2004
Total Cost
$418,750
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Leite, Sérgio Carvalho; Sampaio, Paula; Sousa, Vera Filipe et al. (2016) The Actin-Binding Protein ?-Adducin Is Required for Maintaining Axon Diameter. Cell Rep 15:490-498
Robledo, Raymond F; Seburn, Kevin L; Nicholson, Anthony et al. (2012) Strain-specific hyperkyphosis and megaesophagus in Add1 null mice. Genesis 50:882-91
Wooden, Jason M; Finney, Greg L; Rynes, Eric et al. (2011) Comparative proteomics reveals deficiency of SLC9A1 (sodium/hydrogen exchanger NHE1) in ?-adducin null red cells. Br J Haematol 154:492-501
Robledo, Raymond F; Lambert, Amy J; Birkenmeier, Connie S et al. (2010) Analysis of novel sph (spherocytosis) alleles in mice reveals allele-specific loss of band 3 and adducin in alpha-spectrin-deficient red cells. Blood 115:1804-14
Ferrandi, Mara; Cusi, Daniele; Molinari, Isabella et al. (2010) alpha- and beta-Adducin polymorphisms affect podocyte proteins and proteinuria in rodents and decline of renal function in human IgA nephropathy. J Mol Med (Berl) 88:203-17
Sahr, Kenneth E; Lambert, Amy J; Ciciotte, Steven L et al. (2009) Targeted deletion of the gamma-adducin gene (Add3) in mice reveals differences in alpha-adducin interactions in erythroid and nonerythroid cells. Am J Hematol 84:354-61
Robledo, Raymond F; Ciciotte, Steven L; Gwynn, Babette et al. (2008) Targeted deletion of alpha-adducin results in absent beta- and gamma-adducin, compensated hemolytic anemia, and lethal hydrocephalus in mice. Blood 112:4298-307
Campanella, M Estela; Chu, Haiyan; Wandersee, Nancy J et al. (2008) Characterization of glycolytic enzyme interactions with murine erythrocyte membranes in wild-type and membrane protein knockout mice. Blood 112:3900-6
Chen, Huiqing; Khan, Anwar A; Liu, Fei et al. (2007) Combined deletion of mouse dematin-headpiece and beta-adducin exerts a novel effect on the spectrin-actin junctions leading to erythrocyte fragility and hemolytic anemia. J Biol Chem 282:4124-35
Soni, Shivani; Bala, Shashi; Gwynn, Babette et al. (2006) Absence of erythroblast macrophage protein (Emp) leads to failure of erythroblast nuclear extrusion. J Biol Chem 281:20181-9

Showing the most recent 10 out of 11 publications